These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 36057263)
21. CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis. Yu S; Zhao H; Meng H; Shi S; Cao S; Bian T; Ruan C Genet Res (Camb); 2023; 2023():8586507. PubMed ID: 37113556 [TBL] [Abstract][Full Text] [Related]
22. Contributions of Gene Modules Regulated by Essential Noncoding RNA in Colon Adenocarcinoma Progression. Li C; Yu X; Lu J; Zheng L; Xu D; Xu Z; Wang L; Cui Y; Li Y; Wang H; Xu J; Li K Biomed Res Int; 2020; 2020():8595473. PubMed ID: 32280704 [TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma. Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920 [TBL] [Abstract][Full Text] [Related]
24. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma. Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J Front Immunol; 2022; 13():881359. PubMed ID: 35911752 [TBL] [Abstract][Full Text] [Related]
25. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression. Cui Y; Lv P; Zhang C J Biochem Mol Toxicol; 2024 Jun; 38(6):e23749. PubMed ID: 38800929 [TBL] [Abstract][Full Text] [Related]
26. AEBP1, a prognostic indicator, promotes colon adenocarcinoma cell growth and metastasis through the NF-κB pathway. Xing Y; Zhang Z; Chi F; Zhou Y; Ren S; Zhao Z; Zhu Y; Piao D Mol Carcinog; 2019 Oct; 58(10):1795-1808. PubMed ID: 31219650 [TBL] [Abstract][Full Text] [Related]
27. LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma. Lin Y; Li Y; Chen Y; Zhang Z Medicine (Baltimore); 2022 Oct; 101(42):e31314. PubMed ID: 36281164 [TBL] [Abstract][Full Text] [Related]
28. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma. Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538 [TBL] [Abstract][Full Text] [Related]
29. SSR4 as a prognostic biomarker and related with immune infiltration cells in colon adenocarcinoma. He W; Wang B; He J; Zhao Y; Zhao W Expert Rev Mol Diagn; 2022 Feb; 22(2):223-231. PubMed ID: 34904499 [TBL] [Abstract][Full Text] [Related]
30. Liu L; Jia S; Jin X; Zhu S; Zhang S DNA Cell Biol; 2021 Sep; 40(9):1158-1166. PubMed ID: 34415792 [TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of Shi C; Xie LY; Tang YP; Long L; Li JL; Hu BL; Li KZ Front Genet; 2019; 10():1097. PubMed ID: 31781164 [No Abstract] [Full Text] [Related]
32. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma. Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249 [TBL] [Abstract][Full Text] [Related]
33. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis. Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224 [TBL] [Abstract][Full Text] [Related]
34. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867 [No Abstract] [Full Text] [Related]
35. Identification of key lncRNAs in the carcinogenesis and progression of colon adenocarcinoma by co-expression network analysis. Jiang S; Tan B; Zhang X J Cell Biochem; 2019 Apr; 120(4):6490-6501. PubMed ID: 30430631 [TBL] [Abstract][Full Text] [Related]
36. Identification and verification of the prognostic value of CUL7 in colon adenocarcinoma. Wang C; Zhao Z; Zhang Y; Liang W; Zhou C; Lin W; He Y; Wu M; Meng Z; Liao Y; Li M; El Akkawi M; Zhao J; He Y Front Immunol; 2022; 13():1043512. PubMed ID: 36304472 [TBL] [Abstract][Full Text] [Related]
37. miR-4709 overexpression facilitates cancer proliferation and invasion via downregulating NR3C2 and is an unfavorable prognosis factor in colon adenocarcinoma. Yu M; Yu HL; Li QH; Zhang L; Chen YX J Biochem Mol Toxicol; 2019 Dec; 33(12):e22411. PubMed ID: 31621980 [TBL] [Abstract][Full Text] [Related]
38. High miR-31-5p expression promotes colon adenocarcinoma progression by targeting TNS1. Mi B; Li Q; Li T; Liu G; Sai J Aging (Albany NY); 2020 Apr; 12(8):7480-7490. PubMed ID: 32315285 [TBL] [Abstract][Full Text] [Related]
39. Combined Evaluation of mRNA and Protein Expression, Promoter Methylation, and Immune Infiltration of UBE2I in Pan-Digestive System Tumors. Huang S; Wang X; Luo K; Zhang X; Liu Z; Li R Oxid Med Cell Longev; 2022; 2022():1129062. PubMed ID: 36193060 [TBL] [Abstract][Full Text] [Related]
40. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma. Gao H; Xing F BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]